India"s pharmaceutical market achieves record sales despite slowing growth rates

India"s pharmaceutical market has achieved a significant milestone, with domestic sales reaching Rs 2.25 lakh crore in the 12 months leading up to September 2024. Despite a slowdown in growth rates, the market continues to exhibit strong expansion, making it a crucial sector for pharmaceutical companies.

In the September 2024 quarter, sales rose to Rs 60,000 crore, marking an 8 percent increase compared to the same period last year. This growth is noteworthy when compared to the pre-pandemic December 2019 quarter, which recorded sales of Rs 38,200 crore, highlighting the sector"s resilience and sustained demand.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings